Condition: Substance Use Disorders · Substance Use · Methamphetamine Abuse · Sponsor: University of Texas Southwestern Medical Center
This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week randomized, double-blind, controlled trial comparing intravenous (IV) ketamine against IV midazolam, delivered over six weeks in 120 adults with moderate to severe methamphetamine use disorder (MUD).
This description comes directly from the study's public registry record.
Angela Casey-Willingham · 214-648-4689 · Angela.Casey-Willingham@UTSouthwestern.edu
Always discuss trial participation with your own doctor first.
| Alameda Health System | San Leandro, California, United States | Recruiting |
| Interdisciplinary Substance Use and Brain Injury Facility | Albuquerque, New Mexico, United States | Completed |
| Addiction Institute of Mount Sinai | New York, New York, United States | Terminated |
| Prisma Health | Greenville, South Carolina, United States | Recruiting |
| UT Southwestern Medical Center | Dallas, Texas, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06496750